Summary
This Form 8-K/A filing from Gilead Sciences, Inc. (GILD) serves as an amendment to a previous 8-K filing on August 5, 2008, concerning the election of Dr. Richard J. Whitley to the Board of Directors. The amendment provides additional disclosures regarding Dr. Whitley's prior business relationship with the company, specifically outlining consulting services provided by his company, Viral Interventions, Inc., and by Dr. Whitley himself. These services, related to health policy and strategic consulting, were engaged in on a discrete project basis. Investors should note that the aggregate payments made to Viral Interventions, Inc. and Dr. Whitley individually for these consulting services between January 1, 2007, and July 31, 2008, amounted to approximately $255,329. Importantly, as of Dr. Whitley's appointment to the Board, Viral Interventions, Inc. has ceased providing services to Gilead. This disclosure aims to ensure transparency regarding potential related-party transactions and director independence.
Key Highlights
- 1Gilead Sciences filed an 8-K/A (Amendment No. 1) on August 14, 2008.
- 2The filing amends a prior 8-K dated August 5, 2008, regarding the election of Richard J. Whitley, MD, to the Board of Directors.
- 3Additional disclosures are provided regarding Dr. Whitley's prior business relationship with Gilead Sciences.
- 4Dr. Whitley's company, Viral Interventions, Inc., provided health policy and strategic consulting services.
- 5Payments to Viral Interventions, Inc. and Dr. Whitley individually for consulting services totaled $165,485.39 and $89,843.90 respectively, between January 1, 2007, and July 31, 2008.
- 6Viral Interventions, Inc. ceased providing services to Gilead as of Dr. Whitley's appointment to the Board.